aspirin has been researched along with acyclovir in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Abdel-Maksoud, MS; Ali, EMH; Oh, CH | 1 |
| Balliano, TL; Barbosa, G; Carvalho, VF; da Silva, BA; de Souza, ET; Lima, LM; Martins, IRR; Martins, MA; Medeiros, MM; Moraes Junior, MO; Nunes, IKDC; Silva, PMR; Silva, SWD | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Healy, B | 1 |
| Brockhurst, RJ; Falcone, PM | 1 |
| Akahori, K; Amayasu, H; Hasegawa, H; Nakagawa, H; Onuma, K; Sakamoto, H; Shoji, T; Yamawaki, Y; Yoshida, S | 1 |
| Mateen, FJ; Mohr, DN | 1 |
| Clement, C; Hill, JM; Kaufman, HE; Kumar, M; Thompson, HW; Varnell, ED | 1 |
| Clarke, MJ; Cloft, HJ; Daugherty, WP; Lanzino, GL | 1 |
| Hayashi, M; Katagiri, Y; Kawaguchi, M; Monma, F; Suzuki, T | 1 |
| Bjerrum, SS; Hessellund, A | 1 |
| Bonneville, F; Conil, JM; Crognier, L; Dupuy, M; Fourcade, O; Geeraerts, T; Georges, B; Ruiz, S; Selves, A | 1 |
| Aldazabal, M; Arruti, M; Blanco, A; González, F; López de Munain, A; Piñeiro, L; Zapico, MS | 1 |
| Borkowski, P; Brydak-Godowska, J; Kęcik, D; Moneta-Wielgoś, J; Szczepanik, S | 1 |
| Cronin, S; Fanning, N; McKenna, MC | 1 |
| Itsekson Hayosh, Z; Orion, D; Schwammenthal, Y | 1 |
3 review(s) available for aspirin and acyclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Inflammation; Neoplasms; Pyrimidines; Structure-Activity Relationship | 2019 |
[Acute herpes simplex virus type 1 retinal necrosis three years after herpes simplex encephalitis].
Topics: Acyclovir; Antiviral Agents; Aspirin; Cataract Extraction; Causality; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Methylprednisolone; Middle Aged; Recurrence; Retinal Detachment; Retinal Hemorrhage; Retinal Necrosis Syndrome, Acute; Time Factors; Valacyclovir; Valine; Vitrectomy | 2014 |
2 trial(s) available for aspirin and acyclovir
| Article | Year |
|---|---|
Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma.
Topics: Acyclovir; Administration, Oral; Adult; Anti-Asthmatic Agents; Aspirin; Asthma; Bronchoconstriction; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene E4; Male; Middle Aged; Vital Capacity | 1998 |
A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva.
Topics: Acyclovir; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Aspirin; DNA, Viral; Double-Blind Method; Drug Therapy, Combination; Female; Gene Dosage; Herpesvirus 1, Human; Humans; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Saliva; Tears; Valacyclovir; Valine; Virus Shedding; Young Adult | 2009 |
26 other study(ies) available for aspirin and acyclovir
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; Humans; Hydrazones; Hypersensitivity; Lung; Male; Mice | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
From the National Institutes of Health.
Topics: Acute Disease; Acyclovir; Administration, Oral; Antibodies, Viral; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Embolism; Humans; Immunoassay; Infectious Mononucleosis; National Institutes of Health (U.S.); Simplexvirus; United States; Warfarin | 1991 |
Delayed onset of bilateral acute retinal necrosis syndrome: a 34-year interval.
Topics: Acyclovir; Adolescent; Adult; Aspirin; Follow-Up Studies; Humans; Infusions, Intravenous; Longitudinal Studies; Male; Prednisone; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Visual Acuity | 1993 |
45-year-old woman with recurrent headache and photophobia.
Topics: Acyclovir; Anti-Bacterial Agents; Antiviral Agents; Aspirin; Diagnosis, Differential; Female; Headache; Humans; Meningitis, Viral; Middle Aged; Photophobia; Recurrence; Spinal Puncture; Valacyclovir; Valine | 2008 |
Going viral: fusiform vertebrobasilar and internal carotid aneurysms with varicella angiitis and common variable immunodeficiency.
Topics: Acyclovir; Adolescent; Aneurysm; Angiography, Digital Subtraction; Antiviral Agents; Aspirin; Basilar Artery; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Angiography; Common Variable Immunodeficiency; Female; Herpes Zoster; Humans; Image Processing, Computer-Assisted; Intracranial Aneurysm; Magnetic Resonance Angiography; Platelet Aggregation Inhibitors; T-Lymphocytes; Tomography, X-Ray Computed; Valacyclovir; Valine; Vasculitis; Vertebral Artery | 2009 |
Linear immunoglobulin A bullous dermatosis associated with herpes simplex virus infection and Kawasaki disease.
Topics: Acyclovir; Aspirin; Basement Membrane; Dapsone; Glycoproteins; Herpes Simplex; Humans; Immunization, Passive; Immunoglobulin A; Infant; Male; Mucocutaneous Lymph Node Syndrome; Prednisolone; Skin Diseases, Vesiculobullous | 2010 |
[Complete ophthalmoplegia following outburst of herpes zoster].
Topics: Acyclovir; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Aspirin; Eye Diseases; Female; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Ophthalmoplegia; Ophthalmoscopy; Prednisolone; Vitreous Body | 2012 |
[Aspirin and its danger: Reye syndrome in young adult].
Topics: Acyclovir; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Aspirin; Brain Edema; Coma; Decompressive Craniectomy; Fatal Outcome; Glasgow Coma Scale; Humans; Magnetic Resonance Imaging; Male; Pericarditis; Resuscitation; Reye Syndrome; Seizures; Virus Diseases; Young Adult | 2013 |
Clinical manifestation of self-limiting acute retinal necrosis.
Topics: Acyclovir; Adult; Antiviral Agents; Aspirin; Female; Humans; Male; Middle Aged; Prednisone; Retinal Necrosis Syndrome, Acute; Valacyclovir; Valine; Young Adult | 2014 |
Focal Cerebral Arteriopathy in Young Adult Patients With Stroke.
Topics: Acyclovir; Adult; Antibodies, Viral; Antiviral Agents; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Cerebral Arterial Diseases; Computed Tomography Angiography; Dual Anti-Platelet Therapy; Female; Glucocorticoids; Herpesvirus 3, Human; Humans; Immunoglobulin G; Immunoglobulin M; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Stroke | 2020 |
Can other coronavirus infections cause a cryptogenic stroke in a young patient?
Topics: Acyclovir; Antiviral Agents; Aspirin; Coronavirus Infections; Coronavirus OC43, Human; COVID-19; Humans; Ischemic Stroke; Magnetic Resonance Imaging; Male; Nasopharynx; Platelet Aggregation Inhibitors; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Young Adult | 2021 |